Education
About Us
Working with TipRanks
Follow Us
BrightSpring Health Services, Inc. (BTSG)
NASDAQ:BTSG
BTSG Stock Chart & Stats
$41.77
-$0.12(-0.69%)
At close: 4:00 PM EST
$41.77
-$0.12(-0.69%)
Day’s Range― - ―
52-Week Range$15.48 - $44.87
Previous CloseN/A
Volume351.53K
Average Volume (3M)2.23M
Market Cap
$8.08B
Enterprise Value$10.78B
Total Cash (Recent Filing)$88.37M
Total Debt (Recent Filing)$2.84B
Price to Earnings (P/E)39.8
Beta1.12
Next Earnings
May 01, 2026EPS Estimate
0.3Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.33
Shares Outstanding193,549,160
10 Day Avg. Volume3,758,950
30 Day Avg. Volume2,225,972
Financial Highlights & Ratios
PEG Ratio-0.04
Price to Book (P/B)4.05
Price to Sales (P/S)0.59
P/FCF Ratio19.22
Enterprise Value/Market Cap1.33
Enterprise Value/Revenue0.84
Enterprise Value/Gross Profit7.11
Enterprise Value/Ebitda23.47
Forecast
1Y Price Target
$48.33Price Target Upside15.71% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering13
EPS Forecast (FY)1.53
Revenue Forecast (FY)$14.84B
Bulls Say, Bears Say
Bulls Say
Earnings Guidance And Margin ExpansionCompany guidance aiming for double-digit EBITDA growth in 2026 and a long-term EBITDA growth target near fifteen percent signals expectations of continued margin expansion from market share gains, cost efficiencies, and accretive deals.
Provider Services And M&A OptionalityIntegration of higher-margin Provider Services and selective home-health acquisitions creates a diversified platform that supports organic growth and provides balance-sheet optionality for further expansion.
Specialty Pharmacy GrowthOnco360's consistent wins for new oncology drugs and expansion of limited-distribution drugs can meaningfully boost revenue and improve margins in the specialty pharmacy business.
Bears Say
Acquisition-related Margin DragRecent home health asset acquisitions are expected to reduce EBITDA and pressure margins until operational efficiencies and integration benefits are realized.
Prescription Volume PressureA slight decline in total prescriptions dispensed indicates volume pressure that could cap revenue upside even with higher revenue per script.
Reimbursement And Regulatory UncertaintyUncertainty over home health rate updates and potential recoupments raises the risk of constrained cash flows and a pause in future acquisition activity until clarity is achieved.
BrightSpring Health Services, Inc. News
BTSG FAQ
What was BrightSpring Health Services, Inc.’s price range in the past 12 months?
BrightSpring Health Services, Inc. lowest stock price was $15.48 and its highest was $44.87 in the past 12 months.
What is BrightSpring Health Services, Inc.’s market cap?
BrightSpring Health Services, Inc.’s market cap is $8.08B.
When is BrightSpring Health Services, Inc.’s upcoming earnings report date?
BrightSpring Health Services, Inc.’s upcoming earnings report date is May 01, 2026 which is in 55 days.
How were BrightSpring Health Services, Inc.’s earnings last quarter?
BrightSpring Health Services, Inc. released its earnings results on Feb 27, 2026. The company reported $0.33 earnings per share for the quarter, missing the consensus estimate of $0.346 by -$0.016.
Is BrightSpring Health Services, Inc. overvalued?
According to Wall Street analysts BrightSpring Health Services, Inc.’s price is currently Undervalued.
Does BrightSpring Health Services, Inc. pay dividends?
BrightSpring Health Services, Inc. does not currently pay dividends.
What is BrightSpring Health Services, Inc.’s EPS estimate?
BrightSpring Health Services, Inc.’s EPS estimate is 0.3.
How many shares outstanding does BrightSpring Health Services, Inc. have?
BrightSpring Health Services, Inc. has 193,549,160 shares outstanding.
What happened to BrightSpring Health Services, Inc.’s price movement after its last earnings report?
BrightSpring Health Services, Inc. reported an EPS of $0.33 in its last earnings report, missing expectations of $0.346. Following the earnings report the stock price went up 3.239%.
Which hedge fund is a major shareholder of BrightSpring Health Services, Inc.?
Currently, no hedge funds are holding shares in BTSG
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
BrightSpring Health Services, Inc. Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$48.33 (15.71% Upside)
$48.33 (15.71% Upside)
Blogger Sentiment
Bullish
BTSG Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 71.4K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $1.6B over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 5.6%
Last 30 Days ▲ 4.8%
Last 30 Days ▲ 4.8%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
127.13%
12-Months-Change
Fundamentals
Return on Equity
6.04%
Trailing 12-Months
Asset Growth
3.47%
Trailing 12-Months
Company Description
BrightSpring Health Services, Inc.
BrightSpring Health Services, Inc. operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations. It serves patients through clinical providers and pharmacists. BrightSpring Health Services, Inc. was formerly known as Phoenix Parent Holdings Inc. and changed its name to BrightSpring Health Services, Inc. in May 2021. The company was founded in 1974 and is based in Louisville, Kentucky.
BTSG Company Deck
BTSG Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call was predominantly positive: BrightSpring reported strong 2025 results with robust revenue (28% YoY) and EBITDA (34% YoY) growth, meaningful improvement in cash flow and leverage, high-quality operational metrics across business lines, and confident 2026 guidance (midpoint implying ~14% revenue and ~25% EBITDA growth). Management also outlined strategic M&A activity (Amedisys acquisition) and a pending Community Living divestiture expected to generate ~$715M of net proceeds to further reduce leverage. Offsetting these positives are notable near-term headwinds from IRA and brand-to-generic conversions (gross impacts quantified in the hundreds of millions), disruption from a large customer bankruptcy and exit of uneconomic customers, and integration/timing risk related to acquired assets. Overall, the highlights—strong growth, cash generation, margin expansion, and balance sheet improvement—outweigh the lowlights, which are being actively managed.View all BTSG earnings summariesBTSG Stock 12 Month Forecast
Average Price Target
$48.33
▲(15.71% Upside)
Technical Analysis
Ownership Overview
Currently, No data available
---